Protocols
1 protocol(s) meet the specified criteria
Drug: Entinostat
Protocol No.TitleStatus
LCCC1639A Non-Randomized, Non-Comparative, Open-Label, Window Trial of Entinostat in Subjects with Borderline ER/PR Positive Breast Cancer and TNBC (Part 1) or Entinostat with or without Exemestane in Subjects with Newly Diagnosed, Stage I-IIIC, Hormone Receptor Positive (HR+) Breast Cancer (Part 2)Open